Variant report

Variant	rs10761194
Chromosome Location	chr9:95899884-95899885
allele	A/G
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	EBF1	chr9:95899726-95900170	GM12878	blood:	n/a	chr9:95900020-95900029 chr9:95900018-95900031 chr9:95900018-95900029 chr9:95900019-95900029 chr9:95900020-95900029
2	EBF1	chr9:95899850-95900149	GM12878	blood:	n/a	chr9:95900020-95900029 chr9:95900018-95900031 chr9:95900018-95900029 chr9:95900019-95900029 chr9:95900020-95900029

No.	Distal block	Cell Line	Cell type
1	chr9:95814617..95816296-chr9:95899284..95901959,2	K562	blood:
2	chr9:95893768..95895658-chr9:95897377..95900133,3	K562	blood:
3	chr9:95897165..95898764-chr9:95898859..95901008,2	K562	blood:
4	chr9:95899271..95900949-chr9:95904032..95906228,2	K562	blood:

Variant related genes	Relation type
NINJ1	TF binding region

Extended variants
information (count: 21 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:14)

rs_ID	r²[population]
rs10761195	0.82[CHB][hapmap]
rs10821074	0.91[AFR][1000 genomes];1.00[AMR][1000 genomes];0.95[EUR][1000 genomes];0.98[ASN][1000 genomes]
rs10821075	1.00[CHB][hapmap];1.00[JPT][hapmap];1.00[YRI][hapmap];0.90[AFR][1000 genomes];1.00[AMR][1000 genomes];0.95[EUR][1000 genomes];0.98[ASN][1000 genomes]
rs10821076	1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];1.00[YRI][hapmap];0.97[AFR][1000 genomes];1.00[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs10992648	0.89[CEU][hapmap]
rs12342201	0.94[AFR][1000 genomes];0.83[AMR][1000 genomes]
rs13287380	0.97[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs1833035	0.91[AMR][1000 genomes];0.85[EUR][1000 genomes]
rs34881469	1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs35836942	0.97[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs4744178	0.86[ASN][1000 genomes]
rs7039090	0.90[AFR][1000 genomes];1.00[AMR][1000 genomes];0.94[EUR][1000 genomes];0.98[ASN][1000 genomes]
rs7042420	0.96[AFR][1000 genomes];1.00[AMR][1000 genomes];0.94[EUR][1000 genomes];0.98[ASN][1000 genomes]
rs7043145	0.91[AFR][1000 genomes];1.00[AMR][1000 genomes];0.95[EUR][1000 genomes];0.98[ASN][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:7 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv526296	chr9:95708192-96030392	Enhancers Bivalent/Poised TSS Weak transcription Active TSS Flanking Active TSS Strong transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Genic enhancers ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	30 gene(s)	inside rSNPs	diseases
2	nsv1035230	chr9:95770249-95934982	Weak transcription Active TSS Flanking Active TSS Enhancers Genic enhancers Strong transcription ZNF genes & repeats Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	28 gene(s)	inside rSNPs	diseases
3	nsv893576	chr9:95789960-96158277	Active TSS Weak transcription Enhancers Flanking Active TSS Strong transcription Genic enhancers Transcr. at gene 5' and 3' ZNF genes & repeats Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	29 gene(s)	inside rSNPs	diseases
4	esv1824329	chr9:95811604-95921347	Strong transcription Enhancers Weak transcription Flanking Active TSS ZNF genes & repeats Active TSS Genic enhancers Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	23 gene(s)	inside rSNPs	diseases
5	nsv893579	chr9:95855100-95923091	Enhancers Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Strong transcription Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS Genic enhancers ZNF genes & repeats Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	22 gene(s)	inside rSNPs	diseases
6	nsv893580	chr9:95855100-96099377	Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Weak transcription Genic enhancers Strong transcription Bivalent/Poised TSS Bivalent Enhancer ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	25 gene(s)	inside rSNPs	diseases
7	nsv893581	chr9:95872216-95930334	Enhancers Weak transcription Flanking Active TSS Strong transcription Genic enhancers Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	17 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:56 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:95897200-95900200	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
2	chr9:95897200-95900400	Genic enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
3	chr9:95897200-95900400	Enhancers	Esophagus	oesophagus
4	chr9:95897200-95900400	Enhancers	Fetal Muscle Leg	muscle
5	chr9:95897200-95901000	Enhancers	Brain Cingulate Gyrus	brain
6	chr9:95897200-95902400	Enhancers	Primary B cells from peripheral blood	blood
7	chr9:95897200-95906200	Weak transcription	Right Atrium	heart
8	chr9:95897400-95900400	Enhancers	Breast Myoepithelial Primary Cells	Breast
9	chr9:95897400-95900800	Bivalent Enhancer	Fetal Muscle Trunk	muscle
10	chr9:95897400-95901000	Enhancers	Brain Inferior Temporal Lobe	brain
11	chr9:95897400-95906200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
12	chr9:95897600-95900000	Weak transcription	Fetal Intestine Small	intestine
13	chr9:95897600-95900200	Weak transcription	Primary hematopoietic stem cells	blood
14	chr9:95897600-95904600	Weak transcription	Psoas Muscle	Psoas
15	chr9:95897600-95906000	Weak transcription	Sigmoid Colon	Sigmoid Colon
16	chr9:95897600-95906200	Enhancers	Primary T helper cells PMA-I stimulated	--
17	chr9:95897800-95900200	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
18	chr9:95897800-95900400	Weak transcription	Primary hematopoietic stem cells short term culture	blood
19	chr9:95897800-95900400	Weak transcription	Primary T killer naive cells fromperipheralblood	blood
20	chr9:95897800-95902600	Weak transcription	Primary T helper naive cells from peripheral blood	blood
21	chr9:95897800-95903000	Weak transcription	Primary T helper memory cells from peripheral blood 2	blood
22	chr9:95897800-95903000	Weak transcription	Primary T cells effector/memory enriched fromperipheralblood	blood
23	chr9:95897800-95903000	Weak transcription	Primary T killer memory cells from peripheral blood	blood
24	chr9:95898000-95900000	Weak transcription	Primary B cells from cord blood	blood
25	chr9:95898000-95900200	Weak transcription	Primary T helper cells fromperipheralblood	blood
26	chr9:95898000-95902400	Weak transcription	Primary T helper memory cells from peripheral blood 1	blood
27	chr9:95898000-95904200	Weak transcription	Primary T regulatory cells fromperipheralblood	blood
28	chr9:95898600-95900000	Bivalent Enhancer	HepG2	liver
29	chr9:95898600-95900200	Weak transcription	Primary monocytes fromperipheralblood	blood
30	chr9:95898600-95900200	Weak transcription	Primary T cells from cord blood	blood
31	chr9:95898600-95900200	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
32	chr9:95898600-95900200	Weak transcription	Brain Substantia Nigra	brain
33	chr9:95898600-95900200	Weak transcription	GM12878-XiMat	blood
34	chr9:95898600-95900200	Weak transcription	Monocytes-CD14+_RO01746	blood
35	chr9:95898600-95903200	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
36	chr9:95898600-95904200	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
37	chr9:95898600-95905600	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
38	chr9:95898600-95906200	Weak transcription	Duodenum Mucosa	Duodenum
39	chr9:95899000-95900600	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
40	chr9:95899000-95906200	Enhancers	Primary T cells fromperipheralblood	blood
41	chr9:95899200-95900000	Weak transcription	Brain Anterior Caudate	brain
42	chr9:95899200-95901000	Weak transcription	Skeletal Muscle Female	skeletal muscle
43	chr9:95899200-95901800	Weak transcription	Fetal Adrenal Gland	Adrenal Gland
44	chr9:95899400-95900800	Enhancers	Brain Hippocampus Middle	brain
45	chr9:95899400-95901800	Weak transcription	Skeletal Muscle Male	skeletal muscle
46	chr9:95899400-95906200	Weak transcription	Stomach Smooth Muscle	stomach
47	chr9:95899600-95900000	Enhancers	Spleen	Spleen
48	chr9:95899600-95900000	Enhancers	HMEC	breast
49	chr9:95899600-95900200	Enhancers	Colonic Mucosa	Colon
50	chr9:95899600-95900600	Bivalent/Poised TSS	Foreskin Fibroblast Primary Cells skin02	Skin

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links